ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 736201 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 736201; 2) Community: the network communities that were significantly associated with the response to NSC 736201; 3) Molecule: the relationships between components within communities and NSC 736201; 4) MDR: the compounds that were significantly associated with the NSC 736201.

NSC Compound Enrichment Correlation
NSC 618939 Camptothecin Derivative 0.000260156221906648 0.85120036
NSC 647117 Null 0.000260156221906648 0.31371864
NSC 658103 Null 0.000260156221906648 0.64865614
NSC 659949 14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone 0.000260156221906648 0.69945451
NSC 681636 Camptothecin Derivative 0.000260156221906648 0.79230028
NSC 725774 6-[3-(Bis-hydroxyethylamino)-1-propyl]-5,6-dihydro-2,3-~ dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride 0.000260156221906648 0.70517334
NSC 740524 6-(3-Azidopropyl)-9-fluoro-5,6-dihydro-2,3-dimethoxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.000260156221906649 0.83631618
NSC 742629 Ethylenediaminetetraacetic acid bis-(5-amino salicylic acid methyl ester) 0.000260156221906649 0.6968768
NSC 75520 Thymidine, .alpha.,.alpha.,.alpha.-trifluoro- (8CI 9CI) 0.000260156221906649 0.69213072
NSC 102627 Yoshi 864 0.000272379738694984 0.70855586
Total:108  Current:3    [First] [Prev] [Next] [Last]